IGA NEPHROPATHY
Clinical trials for IGA NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new IGA NEPHROPATHY trials appear
Sign up with your email to follow new studies for IGA NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets common kidney disease
Disease control Not yet recruitingThis study is testing an experimental injection called CM313 for people with IgA nephropathy, a kidney disease. Researchers want to see if the drug is safe and effective at controlling the disease. The trial will enroll about 106 adults who have already been on standard blood pre…
Matched conditions: IGA NEPHROPATHY
Phase: PHASE2 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Tracking kidney disease patients on new medications
Knowledge-focused Not yet recruitingThis study aims to understand how patients with IgA nephropathy (a kidney disease) respond to two newer medications, iptacopan or atrasentan, in real-world clinical practice. It will follow 80 adult patients in China for 24 months to collect information on their health, treatment…
Matched conditions: IGA NEPHROPATHY
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Apr 02, 2026 02:27 UTC